Demographic, clinical, and psychological characteristics of the heartburn groups classified using the rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group

Digestion

Volumn 79, Issue 3, 2009, Pages 131-136

  Lee, Kwang Jae ^a,b   Kwon, Heok Chun ^a   Cheong, Jae Yeon ^a   Cho, Sung Won ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Erosive reflux disease; Functional heartburn; Heartburn; Nonerosive reflux disease; Proton pump inhibitor

Indexed keywords

ESOMEPRAZOLE;

ADULT; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIGESTIVE TRACT ENDOSCOPY; DISEASE CLASSIFICATION; DYSPEPSIA; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REFLUX ESOPHAGITIS; SEX DIFFERENCE; SYMPTOMATOLOGY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ENZYME INHIBITORS; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TREATMENT OUTCOME;

EID: 62649168613     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209848     Document Type: Article

References (26)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920.
2. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA: Functional esophageal disorders. Gut 1999; 45(suppl II):II31-II36.
3. Galmiche JP, Clouse RE, Balint A, et al: Functional esophageal disorders. Gastroenterology 2006; 130: 1459-1465.
4. Fass R: Erosive esophagitis and nonerosive reflux disease: comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007; 41: 131-137.
5. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
6. Trimble KC, Douglas S, Pryde A, et al: Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995; 40: 1098-1104.
7. Fass R, Naliboff B, Higa L, et al: Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivi- ty in humans. Gastroenterology 1998; 115: 1363-1373.
8. Fass R, Tougas G: Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 885-892.
9. Theodoropoulos DS, Pecoraro DL, Lockey RF, et al: Visceral sensitivity in gastroesophageal reflux. Dig Dis Sci 2002; 47: 2554-2564.
10. Hobson AR, Furlong PL, Aziz Q: Oesophageal afferent pathway sensitivity in non-erosive reflux disease. Neurogastroenterol Mo- til 2008; 20: 877-883.
11. Vela MF Camacho-Lobato L. Srinivasan R. et al: Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599-1606.
12. Sifrim D, Holloway R, Silny J, et al: Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120: 1588-1598.
13. Pehlivanov N, Liu J, Mittal RK: Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastroin- test Liver Physiol 2001; 281: G743-G751.
14. Carlsson R, Galmiche JP, Dent I, et al: Prognostic factors influencing relapse of esopha- gitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997; 11: 473-482.
15. Shapiro M, Green C, Bautista JM, et al: Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol 2006; 101: 1084-1091.
16. El-Serag FIB: Epidemiology of non-erosive reflux disease. Digestion 2008; 78(suppl 1): 6-10.
17. Kim TH, Lee KJ, Yeo M, Kim TK, Cho SW: Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion 2008; 77: 201-206.
18. Natashkin I, Mehdikhani E, Conklin J, et al: Studying the overlap between IBS and GERD: a systemic review of the literature. Dig Dis Sci2006; 51: 2113-2120.
19. Dickman R, Feroze H, Fass R: Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep 2006; 8: 261-265.
20. Zimmerman J, Hershcovici T: Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux. J Clin Gastroenterol 2008; 42: 261-265.
21. Neumann H, Monkemuller K, Kandulski A, Malfertheiner P: Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis 2008; 26: 243-247.
22. Van Oudenhove L, Vandenberghe J, Geer- aerts B, et al: Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med 2007;69: 455-463. (Pubitemid 46987889)
23. Geeraerts B, Vandenberghe J, Van Oudenhove L, et al: Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology 2005; 129: 1437-1444.
24. Johnston BT, Lewis SA, Collins JS, McFar-land RJ, Love AH: Acid perception in gastro- oesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995; 30: 1-5.
25. Fass R, Ofman JJ: Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97: 1901-1909.
26. Fullard M, Kang JY, Nelid P, PoullisSS A, Maxwell JD: Systemic review: does gastroesophageal reflux disease progress? Aliment Pharmacol Ther 2006;24:33-45. (Pubitemid 43894003)